Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathy.

Graham-Brown MP, Singh A, Wormleighton J, Brunskill NJ, McCann GP, Barratt J, Burton JO, Xu G.

BMC Nephrol. 2019 Jul 11;20(1):256. doi: 10.1186/s12882-019-1447-2.

2.

Reasons for underreporting of uraemic pruritus in people with chronic kidney disease: A qualitative study.

Aresi G, Rayner HC, Hassan L, Burton JO, Mitra S, Sanders C, Van der Veer SN.

J Pain Symptom Manage. 2019 Jun 19. pii: S0885-3924(19)30343-4. doi: 10.1016/j.jpainsymman.2019.06.010. [Epub ahead of print]

3.

A comparison of the reproducibility of two cine-derived strain software programmes in disease states.

Graham-Brown MP, Gulsin GS, Parke K, Wormleighton J, Lai FY, Athithan L, Arnold JR, Burton JO, McCann GP, Singh AS.

Eur J Radiol. 2019 Apr;113:51-58. doi: 10.1016/j.ejrad.2019.01.026. Epub 2019 Jan 23.

PMID:
30927959
4.

Cardiovascular adaptations associated with exercise in patients on hemodialysis.

Graham-Brown MPM, Jardine MJ, Burton JO.

Semin Dial. 2019 Jul;32(4):361-367. doi: 10.1111/sdi.12789. Epub 2019 Mar 24.

PMID:
30907030
5.

Association of self-reported physical function with survival in patients with chronic kidney disease.

Clarke AL, Zaccardi F, Gould DW, Hull KL, Smith AC, Burton JO, Yates T.

Clin Kidney J. 2019 Feb;12(1):122-128. doi: 10.1093/ckj/sfy080. Epub 2018 Aug 28.

6.

The reproducibility of cardiac magnetic resonance imaging measures of aortic stiffness and their relationship to cardiac structure in prevalent haemodialysis patients.

Graham-Brown MPM, Adenwalla SF, Lai FY, Hunt WH, Parke K, Gulsin G, Burton JO, McCann GP.

Clin Kidney J. 2018 Dec;11(6):864-873. doi: 10.1093/ckj/sfy042. Epub 2018 Jun 21.

7.

Implementing a theory-based intradialytic exercise programme in practice: a quality improvement project.

Young HML, Jeurkar S, Churchward DR, Dungey M, Stensel DJ, Bishop NC, Greenwood SA, Singh SJ, Smith AC, Burton JO.

Clin Kidney J. 2018 Dec;11(6):832-840. doi: 10.1093/ckj/sfy050. Epub 2018 Jul 5.

8.

Exercise during hemodialysis does not affect the phenotype or prothrombotic nature of microparticles but alters their proinflammatory function.

Martin N, Smith AC, Dungey MR, Young HML, Burton JO, Bishop NC.

Physiol Rep. 2018 Sep;6(19):e13825. doi: 10.14814/phy2.13825.

9.

Nocturnal hemodialysis: an underutilized modality?

Burton JO, Graham-Brown MPM.

Curr Opin Nephrol Hypertens. 2018 Nov;27(6):472-477. doi: 10.1097/MNH.0000000000000450. Review.

PMID:
30281539
10.

Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD.

Burton JO, Goldsmith DJ, Ruddock N, Shroff R, Wan M.

BMC Nephrol. 2018 Sep 20;19(1):240. doi: 10.1186/s12882-018-1037-8.

11.

Nocturnal haemodialysis: an underutilized modality?

Burton JO, Graham-Brown MPM.

Curr Opin Nephrol Hypertens. 2018 Aug 16. doi: 10.1097/MNH.0000000000000450. [Epub ahead of print]

PMID:
30124528
12.

Vesicles bearing gifts: the functional importance of micro-RNA transfer in extracellular vesicles in chronic kidney disease.

Abbasian N, Herbert KE, Pawluczyk I, Burton JO, Bevington A.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1430-F1443. doi: 10.1152/ajprenal.00318.2018. Epub 2018 Aug 15.

PMID:
30110570
13.

Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance.

Graham-Brown MP, Singh AS, Gulsin GS, Levelt E, Arnold JA, Stensel DJ, Burton JO, McCann GP.

BMC Cardiovasc Disord. 2018 Jul 13;18(1):145. doi: 10.1186/s12872-018-0885-2.

14.

Sézary Syndrome Presenting With Renal Involvement.

Wickenden K, Graham-Brown MPM, Veitch D, Dormer J, Bamford M, Graham-Brown RAC, Warwick G, Wagner S, Burton JO.

Am J Kidney Dis. 2018 Dec;72(6):890-894. doi: 10.1053/j.ajkd.2018.04.013. Epub 2018 Jun 22.

PMID:
29941220
15.

Effects of intradialytic cycling exercise on exercise capacity, quality of life, physical function and cardiovascular measures in adult haemodialysis patients: a systematic review and meta-analysis.

Young HML, March DS, Graham-Brown MPM, Jones AW, Curtis F, Grantham CS, Churchward DR, Highton P, Smith AC, Singh SJ, Bridle C, Burton JO.

Nephrol Dial Transplant. 2018 Aug 1;33(8):1436-1445. doi: 10.1093/ndt/gfy045.

PMID:
29608708
16.

Microparticles and Exercise in Clinical Populations.

Highton PJ, Martin N, Smith AC, Burton JO, Bishop NC.

Exerc Immunol Rev. 2018;24:46-58. Review.

17.

Regular exercise during haemodialysis promotes an anti-inflammatory leucocyte profile.

Dungey M, Young HML, Churchward DR, Burton JO, Smith AC, Bishop NC.

Clin Kidney J. 2017 Dec;10(6):813-821. doi: 10.1093/ckj/sfx015. Epub 2017 Mar 27.

18.

Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy.

Brown SA, Tyrer FC, Clarke AL, Lloyd-Davies LH, Stein AG, Tarrant C, Burton JO, Smith AC.

Clin Kidney J. 2017 Dec;10(6):788-796. doi: 10.1093/ckj/sfx057. Epub 2017 Jul 10.

19.

Cardiac Remodelling in Patients Undergoing in-Centre Nocturnal Haemodialysis: Results from the MIDNIGHT Study, a Non-Randomized Controlled Trial.

Graham-Brown MPM, Churchward DR, Hull KL, Preston R, Pickering WP, Eborall HC, McCann GP, Burton JO.

Blood Purif. 2017;44(4):301-310. doi: 10.1159/000481248. Epub 2017 Oct 31.

20.

The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.

Adenwalla SF, Graham-Brown MPM, Leone FMT, Burton JO, McCann GP.

Clin Kidney J. 2017 Aug;10(4):503-515. doi: 10.1093/ckj/sfx028. Epub 2017 May 10.

21.

The Potential Cardiovascular Benefits of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysis Fluids: A Review of the Literature.

Grantham CE, Hull KL, Graham-Brown MPM, March DS, Burton JO.

Perit Dial Int. 2017 Jul-Aug;37(4):375-383. doi: 10.3747/pdi.2016.00228. Review.

PMID:
28676508
22.

'There is nothing more deceptive than an obvious fact': more evidence for the prescription of exercise during haemodialysis (intradialytic exercise) is still required.

March DS, Graham-Brown MP, Young HM, Greenwood SA, Burton JO.

Br J Sports Med. 2017 Sep;51(18):1379. doi: 10.1136/bjsports-2017-097542. Epub 2017 Mar 30. No abstract available.

PMID:
28360144
23.

Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities.

Graham-Brown MP, Patel AS, Stensel DJ, March DS, Marsh AM, McAdam J, McCann GP, Burton JO.

Biomed Res Int. 2017;2017:5453606. doi: 10.1155/2017/5453606. Epub 2017 Mar 2. Review.

24.

Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.

Graham-Brown MP, Rutherford E, Levelt E, March DS, Churchward DR, Stensel DJ, McComb C, Mangion K, Cockburn S, Berry C, Moon JC, Mark PB, Burton JO, McCann GP.

J Cardiovasc Magn Reson. 2017 Feb 27;19(1):21. doi: 10.1186/s12968-017-0337-7.

25.

Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.

March DS, Graham-Brown MP, Stover CM, Bishop NC, Burton JO.

Biomed Res Int. 2017;2017:5765417. doi: 10.1155/2017/5765417. Epub 2017 Jan 17. Review.

26.

Potentially pathogenic circulating autoantibodies to cardiac troponin are present in hemodialysis patients.

Jefferies HJ, Tertti R, Wittfooth S, Burton JO, Metsärinne K, Pettersson K, McIntyre CW.

Hemodial Int. 2017 Oct;21(4):519-523. doi: 10.1111/hdi.12514. Epub 2016 Nov 20.

PMID:
27866393
27.

Induction treatment of previously undiagnosed ANCA-associated vasculitis in a renal transplant patient with Rituximab.

Graham-Brown MP, Aljayyousi R, Baines RJ, Burton JO, Brunskill NJ, Furness P, Topham P.

Oxf Med Case Reports. 2016 Oct 1;2016(10):omw073. eCollection 2016 Oct.

28.

Novel cardiac nuclear magnetic resonance method for noninvasive assessment of myocardial fibrosis in hemodialysis patients.

Graham-Brown MP, March DS, Churchward DR, Stensel DJ, Singh A, Arnold R, Burton JO, McCann GP.

Kidney Int. 2016 Oct;90(4):835-44. doi: 10.1016/j.kint.2016.07.014.

PMID:
27633869
29.

Investigating the effects of 6 months extended duration, in-centre nocturnal versus conventional haemodialysis treatment: a non-randomised, controlled feasibility study.

Churchward DR, Graham-Brown MP, Preston R, Pickering W, McCann GP, Burton JO.

BMJ Open. 2016 Sep 8;6(9):e012583. doi: 10.1136/bmjopen-2016-012583.

30.

Design and methods of CYCLE-HD: improving cardiovascular health in patients with end stage renal disease using a structured programme of exercise: a randomised control trial.

Graham-Brown MP, March DS, Churchward DR, Young HM, Dungey M, Lloyd S, Brunskill NJ, Smith AC, McCann GP, Burton JO.

BMC Nephrol. 2016 Jul 8;17(1):69. doi: 10.1186/s12882-016-0294-7.

31.

The use of T1 mapping to define myocardial fibrosis in haemodialysis patients.

Graham-Brown MP, Burton JO, McCann GP.

Eur Heart J Cardiovasc Imaging. 2016 Jul;17(7):832. doi: 10.1093/ehjci/jew076. Epub 2016 Apr 13. No abstract available.

PMID:
27076362
32.

The Impact of Exercising During Haemodialysis on Blood Pressure, Markers of Cardiac Injury and Systemic Inflammation--Preliminary Results of a Pilot Study.

Dungey M, Bishop NC, Young HM, Burton JO, Smith AC.

Kidney Blood Press Res. 2015;40(6):593-604. doi: 10.1159/000368535. Epub 2015 Nov 18.

33.

A 4-month programme of in-centre nocturnal haemodialysis was associated with improvements in patient outcomes.

Graham-Brown MP, Churchward DR, Smith AC, Baines RJ, Burton JO.

Clin Kidney J. 2015 Dec;8(6):789-95. doi: 10.1093/ckj/sfv096. Epub 2015 Oct 6.

34.

Epicardial adipose tissue in patients with end-stage renal disease on haemodialysis.

Graham-Brown MP, McCann GP, Burton JO.

Curr Opin Nephrol Hypertens. 2015 Nov;24(6):517-24. doi: 10.1097/MNH.0000000000000161. Review.

PMID:
26335554
35.

Patient and Staff Perceptions of Intradialytic Exercise before and after Implementation: A Qualitative Study.

Young HM, Hudson N, Clarke AL, Dungey M, Feehally J, Burton JO, Smith AC.

PLoS One. 2015 Jun 12;10(6):e0128995. doi: 10.1371/journal.pone.0128995. eCollection 2015.

36.

Motivations and barriers to exercise in chronic kidney disease: a qualitative study.

Clarke AL, Young HM, Hull KL, Hudson N, Burton JO, Smith AC.

Nephrol Dial Transplant. 2015 Nov;30(11):1885-92. doi: 10.1093/ndt/gfv208. Epub 2015 Jun 7.

PMID:
26056174
37.

Elevated serum free pregnancy-associated plasma protein-A independently predicts mortality in haemodialysis patients but is not associated with recurrent haemodialysis-induced ischaemic myocardial injury.

Jefferies HJ, Tertti R, Wittfooth S, Burton JO, Metsärinne K, Pettersson K, McIntyre CW.

Nephron. 2015;129(3):171-8. doi: 10.1159/000369557. Epub 2015 Mar 6.

PMID:
25766334
38.

Hyperphosphatemia, Phosphoprotein Phosphatases, and Microparticle Release in Vascular Endothelial Cells.

Abbasian N, Burton JO, Herbert KE, Tregunna BE, Brown JR, Ghaderi-Najafabadi M, Brunskill NJ, Goodall AH, Bevington A.

J Am Soc Nephrol. 2015 Sep;26(9):2152-62. doi: 10.1681/ASN.2014070642. Epub 2015 Mar 5.

39.

Establishing a supportive care register improves end-of-life care for patients with advanced chronic kidney disease.

Harrison JK, Clipsham LE, Cooke CM, Warwick G, Burton JO.

Nephron. 2015;129(3):209-13. doi: 10.1159/000371888. Epub 2015 Feb 18.

PMID:
25721712
40.

A delayed case of radiation nephropathy.

Burton JO, Youssouf S, Dormer JP, Furness PN.

Kidney Int. 2014 Nov;86(5):1063. doi: 10.1038/ki.2014.127. No abstract available.

41.

Dialysis.

McIntyre CW, Burton JO.

BMJ. 2014 Jan 2;348:g2. doi: 10.1136/bmj.g2. No abstract available.

PMID:
24384463
42.

Elevated levels of procoagulant plasma microvesicles in dialysis patients.

Burton JO, Hamali HA, Singh R, Abbasian N, Parsons R, Patel AK, Goodall AH, Brunskill NJ.

PLoS One. 2013 Aug 2;8(8):e72663. doi: 10.1371/journal.pone.0072663. Print 2013.

43.

N-terminal Pro-B-type natriuretic peptide and its correlation to haemodialysis-induced myocardial stunning.

Breidthardt T, Burton JO, Odudu A, Eldehni MT, Jefferies H, McIntyre CW.

Nephron Clin Pract. 2013;123(1-2):118-22. doi: 10.1159/000351190. Epub 2013 Jul 18.

PMID:
23880872
44.

Inflammatory factors and exercise in chronic kidney disease.

Dungey M, Hull KL, Smith AC, Burton JO, Bishop NC.

Int J Endocrinol. 2013;2013:569831. doi: 10.1155/2013/569831. Epub 2013 May 13.

45.

New Zealand's first two-pair kidney transplant chain.

Voitov K, Burton J, Muthu C.

N Z Med J. 2012 Oct 26;125(1364):98-101.

PMID:
23242403
46.

Differences in medical care usage between two mass-gathering sporting events.

Burton JO, Corry SJ, Lewis G, Priestman WS.

Prehosp Disaster Med. 2012 Oct;27(5):458-62. doi: 10.1017/S1049023X12000830. Epub 2012 Jul 5.

PMID:
22874523
47.

Sometimes when you hear hoof beats, it could be a zebra: consider the diagnosis of Fabry disease.

Burton JO, Dormer JP, Binns HE, Pickering WP.

BMC Nephrol. 2012 Jul 31;13:73. doi: 10.1186/1471-2369-13-73.

48.

Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients.

Breidthardt T, Burton JO, Odudu A, Eldehni MT, Jefferies HJ, McIntyre CW.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1285-92. doi: 10.2215/CJN.00460112. Epub 2012 Jul 19.

49.

Endotoxaemia in haemodialysis: a novel factor in erythropoetin resistance?

Harrison LE, Burton JO, Szeto CC, Li PK, McIntyre CW.

PLoS One. 2012;7(6):e40209. doi: 10.1371/journal.pone.0040209. Epub 2012 Jun 29.

50.

Exercise in kidney disease and diabetes: time for action.

Smith AC, Burton JO.

J Ren Care. 2012 Feb;38 Suppl 1:52-8. doi: 10.1111/j.1755-6686.2012.00279.x.

PMID:
22348364

Supplemental Content

Loading ...
Support Center